Cargando…
An update on the Pharmacovigilance Programme of India
Autores principales: | Lihite, Ratan J., Lahkar, Mangala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585088/ https://www.ncbi.nlm.nih.gov/pubmed/26441651 http://dx.doi.org/10.3389/fphar.2015.00194 |
Ejemplares similares
-
Pharmacovigilance Programme of India: Recent developments and future perspectives
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016) -
Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023) -
Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India
por: Agrawal, Vijit, et al.
Publicado: (2019) -
Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2014) -
Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer’s Disease-Like Complications of Diabetes
por: Pardeshi, Rohit, et al.
Publicado: (2019)